NASDAQ
Barinthus Biotherapeutics plc (BRNS) has a current ratio of 7.77x as of Monday, May 25, 2026. This represents a 46.64% decrease compared to its 12-month average of 14.55x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.